Optiscan CEO Dr. Camile Farah was recently featured in a video interview with the Stock Network, discussing the company’s remarkable growth and strategic milestones over the past year.

The interview highlights Optiscan's 170% share increase and focuses on key developments, including the launch of the InVue surgical precision platform, a new collaboration with the Mayo Clinic, and advancements in telepathology. Dr. Farah also shared the company's focus on expanding regulatory submissions and increasing revenue from its life sciences and veterinary medicine products.

Watch the full interview here.